Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, March 2014 (p4)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

91-140 of about 5 000 reports
Gemcitabine: Pipeline™ Developer: Patent Report

Gemcitabine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Lansoprazole: Pipeline™ Developer: Patent Report

Lansoprazole: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pravastatin: Pipeline™ Developer: Patent Report

Pravastatin: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Olanzapine: Pipeline™ Developer: Patent Report

Olanzapine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Ropivacaine: Pipeline™ Developer: Patent Report

Ropivacaine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pregabalin: Pipeline™ Developer: Patent Report

Pregabalin: Pipeline™ Developer: Patent Report

  • $ 1 916
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014

Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 159 companies plus partners developing 203 calcium signaling pathway targeting drugs in 799 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug and Medication
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014

VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. ...

  • Industries : Drug and Medication
Gastrointestinal Cancer Drug Pathway Analyzer 2014

Gastrointestinal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 185 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Cell Cycle Targeting in Cancer Drug Pipeline Update 2014

Cell Cycle Targeting in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 144 companies plus partners developing 160 targeting the cell cycle drugs in 536 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ...

  • Industries : Drug and Medication
Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 532 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
MicroRNAs in Cancer Drug Pipeline Update 2014

MicroRNAs in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 10 companies plus partners developing 10 metabolic pathways targeting drugs in 22 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2014

Lung Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 487 targeted molecular therapies known to affect more than 254 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2014

Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the ...

  • Industries : Drug and Medication
Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2014

Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pipeline Update 2014

Ovarian Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Drug and Medication
Hematological Cancers Drug Pathway Analyzer 2014

Hematological Cancers Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Brain Cancer Drug Pipeline Update 2014

Brain Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pipeline Update 2014

Pancreatic Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 270 companies plus partners developing 318 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

  • Industries : Drug and Medication
Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 219 companies plus partners developing 290 transcriptional misregulation targeting drugs in 1153 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated ...

  • Industries : Drug and Medication
Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Drug and Medication
Renal Cancer Drug Pathway Analyzer 2014

Renal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 221 targeted molecular therapies known to affect more than 240 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pipeline Update 2014

Prostate Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...

  • Industries : Drug and Medication
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. ...

  • Industries : Drug and Medication

» Read our Company Profiles

85 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.